Pharmacokinetics and tissue penetration of tazobactam and piperacillin in patients undergoing colorectal surgery.

por Kinzig, M, Sörgel, F, Brismar, B, Nord, C E
Publicado en Antimicrob Agents Chemother (1992)

Influence of changes in pancreatic tissue morphology and capillary blood flow on antibiotic tissue concentrations in the pancreas during the progression of acute pancreatitis.

por Foitzik, T, Hotz, H G, Kinzig, M, Sörgel, F, Buhr, H J
Publicado en Gut (1997)

New Semiphysiological Absorption Model To Assess the Pharmacodynamic Profile of Cefuroxime Axetil Using Nonparametric and Parametric Population Pharmacokinetics

por Bulitta, J. B., Landersdorfer, C. B., Kinzig, M., Holzgrabe, U., Sorgel, F.
Publicado 2009

Pharmacokinetics of fleroxacin after multiple oral dosing in patients receiving regular hemodialysis.

por Uehlinger, D E, Schaedeli, F, Kinzig, M, Sörgel, F, Frey, F J
Publicado en Antimicrob Agents Chemother (1996)

Kinetics of ofloxacin and its metabolites in cerebrospinal fluid after a single intravenous infusion of 400 milligrams of ofloxacin.

por Nau, R, Kinzig, M, Dreyhaupt, T, Kolenda, H, Sörgel, F, Prange, H W
Publicado en Antimicrob Agents Chemother (1994)

Penetration of Meropenem into Epithelial Lining Fluid of Patients with Ventilator-Associated Pneumonia

por Lodise, T. P., Sorgel, F., Melnick, D., Mason, B., Kinzig, M., Drusano, G. L.
Publicado 2011

Comparable Population Pharmacokinetics and Pharmacodynamic Breakpoints of Cefpirome in Cystic Fibrosis Patients and Healthy Volunteers

por Bulitta, J. B., Kinzig, M., Landersdorfer, C. B., Holzgrabe, U., Stephan, U., Sörgel, F.
Publicado 2011

Blood, Tissue, and Intracellular Concentrations of Erythromycin and Its Metabolite Anhydroerythromycin during and after Therapy

por Krasniqi, S., Matzneller, P., Kinzig, M., Sörgel, F., Hüttner, S., Lackner, E., Müller, M., Zeitlinger, M.
Publicado 2012

Blood, Tissue, and Intracellular Concentrations of Azithromycin during and after End of Therapy

por Matzneller, P., Krasniqi, S., Kinzig, M., Sörgel, F., Hüttner, S., Lackner, E., Müller, M., Zeitlinger, M.
Publicado 2013

Ex vivo pharmacodynamic study of piperacillin alone and in combination with tazobactam, compared with ticarcillin plus clavulanic acid.

por Van der Auwera, P, Duchateau, V, Lambert, C, Husson, M, Kinzig, M, Sörgel, F
Publicado en Antimicrob Agents Chemother (1993)

Penetration of piperacillin-tazobactam into cancellous and cortical bone tissues.

por Incavo, S J, Ronchetti, P J, Choi, J H, Wu, H, Kinzig, M, Sörgel, F
Publicado en Antimicrob Agents Chemother (1994)

Cerebrospinal fluid ceftazidime kinetics in patients with external ventriculostomies.

por Nau, R, Prange, H W, Kinzig, M, Frank, A, Dressel, A, Scholz, P, Kolenda, H, Sörgel, F
Publicado en Antimicrob Agents Chemother (1996)

Population Pharmacokinetic Comparison and Pharmacodynamic Breakpoints of Ceftazidime in Cystic Fibrosis Patients and Healthy Volunteers

por Bulitta, J. B., Landersdorfer, C. B., Hüttner, S. J., Drusano, G. L., Kinzig, M., Holzgrabe, U., Stephan, U., Sörgel, F.
Publicado 2010

Impact of Spore Biology on the Rate of Kill and Suppression of Resistance in Bacillus anthracis

por Drusano, G. L., Okusanya, O. O., Okusanya, A. O., van Scoy, B., Brown, D. L., Fregeau, C., Kulawy, R., Kinzig, M., Sörgel, F., Heine, H. S., Louie, A.
Publicado 2009

Population Modeling Integrating Pharmacokinetics, Pharmacodynamics, Pharmacogenetics, and Clinical Outcome in Patients With Sunitinib‐Treated Cancer

por Diekstra, MH, Fritsch, A, Kanefendt, F, Swen, JJ, Moes, DJAR, Sörgel, F, Kinzig, M, Stelzer, C, Schindele, D, Gauler, T, Hauser, S, Houtsma, D, Roessler, M, Moritz, B, Mross, K, Bergmann, L, Oosterwijk, E, Kiemeney, LA, Guchelaar, HJ, Jaehde, U
Publicado en CPT Pharmacometrics Syst Pharmacol (2017)